Date published: 2026-2-2

1-800-457-3801

SCBT Portrait Logo
Seach Input

VP 14637 (CAS 235106-62-4)

5.0(1)
Write a reviewAsk a question

Alternate Names:
2,2'-[(4-Hydroxyphenyl)Methylene]bis[4-[[(5-Methyl-1H-tetrazol-1-yl)iMino]Methyl]phenol
Application:
VP 14637 is VP 14637 inhibits human respiratory syncytial virus (HRSV)
CAS Number:
235106-62-4
Molecular Weight:
510.51
Molecular Formula:
C25H22N10O3
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.
* Refer to Certificate of Analysis for lot specific data.

QUICK LINKS

VP 14637 is a chemical compound that has been explored in various scientific research contexts, particularly for its role in studying viral entry mechanisms. This compound is known for its specific interaction with viral components that are crucial for the early stages of viral infection. The primary focus of research on VP 14637 is its action as an entry inhibitor, which provides valuable insights into the prevention of viral propagation at a cellular level. The mechanism of action of VP 14637 involves the inhibition of the fusion between the viral envelope and the host cell membrane. It targets a specific protein or a set of proteins involved in the viral fusion machinery, which are essential for the virus to enter the host cell. By binding to these proteins, VP 14637 prevents the conformational changes required for the fusion of viral and cellular membranes, thereby blocking the virus from injecting its genetic material into the host cell. This action of VP 14637 has been particularly valuable in research focusing on viruses that use a well-defined fusion process to enter cells. Studies have used VP 14637 to better understand the specific steps and molecular interactions involved in viral entry. By inhibiting this process, researchers can dissect the sequence of events and identify potential targets for more effective inhibitors. Moreover, VP 14637 has been used in structural studies to explain the architecture of viral fusion proteins. By interacting with these proteins, VP 14637 helps stabilize them in a particular conformation that is amenable to analysis by techniques such as X-ray crystallography or cryo-electron microscopy. These studies provide a detailed view of the viral components at the atomic level, contributing to a deeper understanding of how viruses orchestrate entry into host cells.


VP 14637 (CAS 235106-62-4) References

  1. VP-14637 ViroPharma.  |  McKimm-Breschkin, J. 2000. Curr Opin Investig Drugs. 1: 425-7. PMID: 11249694
  2. Inhibition of respiratory syncytial virus fusion by the small molecule VP-14637 via specific interactions with F protein.  |  Douglas, JL., et al. 2003. J Virol. 77: 5054-64. PMID: 12692208
  3. In search of a small-molecule inhibitor for respiratory syncytial virus.  |  Douglas, JL. 2004. Expert Rev Anti Infect Ther. 2: 625-39. PMID: 15482225
  4. Small molecules VP-14637 and JNJ-2408068 inhibit respiratory syncytial virus fusion by similar mechanisms.  |  Douglas, JL., et al. 2005. Antimicrob Agents Chemother. 49: 2460-6. PMID: 15917547
  5. Cold virus fusion or stopping fusion cold--inhibitors of the human respiratory syncytial virus F protein.  |  Del Vecchio, AM. and Sarisky, RT. 2006. Recent Pat Antiinfect Drug Discov. 1: 247-54. PMID: 18221150
  6. Pharmacotherapy of respiratory syncytial virus infection.  |  Welliver, RC. 2010. Curr Opin Pharmacol. 10: 289-93. PMID: 20493773
  7. Respiratory syncytial virus entry inhibitors targeting the F protein.  |  Sun, Z., et al. 2013. Viruses. 5: 211-25. PMID: 23325327
  8. GS-5806 Inhibits a Broad Range of Respiratory Syncytial Virus Clinical Isolates by Blocking the Virus-Cell Fusion Process.  |  Perron, M., et al. 2015. Antimicrob Agents Chemother. 60: 1264-73. PMID: 26666922
  9. Respiratory syncytial virus: prospects for new and emerging therapeutics.  |  Jorquera, PA. and Tripp, RA. 2017. Expert Rev Respir Med. 11: 609-615. PMID: 28574729
  10. Pharmacological Characterization of TP0591816, a Novel Macrocyclic Respiratory Syncytial Virus Fusion Inhibitor with Antiviral Activity against F Protein Mutants.  |  Yoshida, I., et al. 2020. Antimicrob Agents Chemother. 65: PMID: 33046486

Ordering Information

Product NameCatalog #UNITPriceQtyFAVORITES

VP 14637, 10 mg

sc-391297
10 mg
$396.00